Hanmi Pharmaceutical, Co., Ltd., established in 1973 and headquartered in Seoul, South Korea, is one of the largest companies in Korea selling over 200 products worldwide. The company is involved in new biologics, new chemical entities, and innovative new drugs. Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10-15% of the company’s annual revenue in developing next-generation Platform Technologies & NCE products.
| Company Name | Hanmi Pharma |
|---|---|
| Industry | Healthcare |
| HQ Address | Seoul, South Korea |
| Revenue | KRW 1,075.9 Billion |
| Employee Size | 2419 |
| Company Type | Public |
| Fiscal Year-End | February 4th |
| Website | www.hanmipharm.com |
| Subsidiaries | Hanmi Fine Chemical Co. Ltd, HanmiIT.CO.,Ltd., and Beijing Hanmi Pharmaceutical Co. Ltd, |
| Locations | Hwaseong, Songpa, and Pyeongtaek |
| Competitors | TCI Co., Ltd, Ono Pharmaceutical, Contract Pharmacal |
| Recognition & Awards | Commendation by the Minister of Health and Welfare |
Access Company's Structure and Understand its Departments
Get Access to Company's Performance and Make Informed Decisions
Get Key Executives Contact to Enhance your Sales Strategy
Understand Company's Partners and Identify Potential Areas for Collaboration
Identify Company's Key Rivals for Competitive Edge
Gain Insight into Technology Partners and Access Exclusive Information on Key Tech Partners
Explore Customer Review to Understand its Service and Pinpoints
Analyse Company Strategies to Gain Market Insights and Stay Ahead of Your Competitors